Ki Summary

Reaction Details

Report a problem with these data

Target

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A [226-593]

Ligand

BDBM14776

Substrate/Competitor

BDBM14391

IC50

680±n/a nM

Citation

Card, GL; England, BP; Suzuki, Y; Fong, D; Powell, B; Lee, B; Luu, C; Tabrizizad, M; Gillette, S; Ibrahim, PN; Artis, DR; Bollag, G; Milburn, MV; Kim, SH; Schlessinger, J; Zhang, KY Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure12:2233-47 (2004) [PubMed] Article

More Info.:

Get all data from this article, Solution Info, Assay Method

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A [226-593]

Name:

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A [226-593]

Synonyms:

High-affinity cGMP-specific 3,5-cyclic phosphodiesterase 9A | PDE9A | PDE9A_HUMAN | Phosphodiesterase Type 9 (PDE9A)

Type:

Enzyme Catalytic Domain

Mol. Mass.:

43183.20

Organism:

Homo sapiens (Human)

Description:

Recombinant catalytic domain (S226-A593) of human PDE9A.

Residue:

368

Sequence:

SFLDNHKKLTPRRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLV
RDFSINPVTLRRWLFCVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILIL
MTAAICHDLDHPGYNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIP
PDGFKQIRQGMITLILATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISN
EVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMF
ETVTKLFPMVEEIMLQPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDV
KNSEGDCA

BDBM14776

BDBM14391

Name

BDBM14776

Synonyms:

2-{2-ethoxy-5-[(4-ethylpiperazine-1-)sulfonyl]phenyl}-5-methyl-7-propyl-3H,4H-imidazo[1,5-a][1,2,4]triazin-4-one | CHEMBL1520 | Vardenafil | citric acid;2-[2-ethoxy-5-(4-ethylpiperazino)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one

Type

Small organic molecule

Emp. Form.

C23H32N6O4S

Mol. Mass.

488.603

SMILES

CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1

Structure